NCT00458250View on ClinicalTrials.gov

Feasibility of Haploidentical Hematopoietic Stem Cell Transplantation Using CAMPATH-1H

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 30, 2006

Study Completion Date

February 29, 2008

Conditions
Leukemia, Myeloid, AcuteLeukemia, Lymphoblastic, Acute
Interventions
PROCEDURE

Haploidentical hematopoietic stem cell transplantation

DRUG

Busulfan

DRUG

Cyclophosphamide

DRUG

CAMPATH-1H

DRUG

Cyclosporin A

DRUG

Methotrexate

Trial Locations (1)

14114

Hematology-Oncology & BMT Research Center, Tehran

All Listed Sponsors
lead

Tehran University of Medical Sciences

OTHER

NCT00458250 - Feasibility of Haploidentical Hematopoietic Stem Cell Transplantation Using CAMPATH-1H | Biotech Hunter | Biotech Hunter